Franziska Trudzinski, MD: Identifying Gender-Specific Pulmonary Disorders in COPDMay 18th 2022
Dr. Trudzinski speaks of the importance of diagnosing sex-specific pulmonary and extra-pulmonary comorbidities in women with COPD, as well as the lack of research regarding COPD prevalence in women.
Study Identifies Pathogenic Cell States, Transcriptional Programs Specific to AsthmaMay 18th 2022
In particular, airway epithelial cells (AEC) in allergic asthmatic (AA) were shown to upregulate mucus metaplasia, matrix-remodeling, and glycolytic programs while failing to upregulate antioxidant genes.
Edward Chen, MD: Amassing Data on Sarcoidosis Prevalence in Rural and Suburban Areas in the USMay 17th 2022
With this new decade-long cohort, Dr. Chen notes that researchers are "one step closer to a more accurate view of what sarcoidosis may be like in the United States", with has been suggested to be more prominent in African American communities.
David Au, MD, MS: Lifestyle Interventions for Weight Loss in Obese Patients with COPDMay 16th 2022
Dr. Au spoke of how the new data provides an opportunity to think about how lifestyle intervention focused on weight and moderate exercise can actually have meaningful impacts on patients with COPD.
Nijira Lucia Lugogo, MD: Effectively Monitoring SABA Use with Digital Inhaler TechnologyMay 16th 2022
Dr. Lugogo explains how the ProAir Digihaler was used to accurately monitor SABA use in patients with asthma -many of whom were overusing their medication- which could allow clinicians to make appropriate changes to treatment.
OSPREY Trial Suggests THN Therapy Effective in Moderate to Severe OSAMay 15th 2022
Investigators from this ATS session suggested THN therapy could be used to treat OSA, believing in to be “a simpler approach than incumbent technology with no sensor and an easier, proximal electrode implantation”.